Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs First Trust Cloud Computing ETF (SKYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs First Trust Cloud Computing ETF — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.95 (market cap $25.27B), while First Trust Cloud Computing ETF trades at $174.78 (market cap $3.47B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 7.3× First Trust Cloud Computing ETF's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while First Trust Cloud Computing ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and First Trust Cloud Computing ETF for 85 Days on average.
| RPRX | SKYY | |
|---|---|---|
Market Cap | $25.27B | $3.47B |
Volume | 3,671,183 | 176,159 |
Sector | Health | — |
52-Week High | $63.96 | $171.01 |
52-Week Low | $35.44 | $104.16 |
Typical Hold Time | 1 Days | 85 Days |
Enterprise Value | $32.50B | — |
Dividend Yield | 1.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
First Trust Cloud Computing ETF (SKYY) trades at $174.09, up 1.94% with bullish technical signals from moving averages. The ETF recently hit a new 52-week high, reflecting strong momentum in cloud computing stocks driven by AI infrastructure demand. Technical indicators show support at $169 and resistance at $171-173, with the current price near recent highs.
SKYY offers diversified exposure to cloud infrastructure and software companies benefiting from secular trends in AI adoption and digital transformation. Key risks include sector concentration and market volatility, while institutional sentiment remains positive given the long-term growth prospects in cloud computing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About First Trust Cloud Computing ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →
